Sharemaestro Newsreel

Exelixis (EXEL) Is Down 5.2% After Raising Q2 Profitability And Trimming 2026 Revenue Outlook – Has The Bull Case Changed?

Editas Medicine Inc (EDIT) Stock Price, Trades & News

Novo Nordisk (CPSE:NOVO B) Could Be 65% Undervalued Following Its Interim Dividend

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Novo Nordisk (CPSE:NOVO B) just confirmed an interim cash dividend of DKK 3.75 per share for 2026, with the stock set to trade …

How Rapport Therapeutics Inc. (RAPP) Affects Rotational Strategy Timing

This article analyzes Rapport Therapeutics Inc. (RAPP) using AI models to determine its effect on rotational strategy timing. Key findings suggest a strong sentiment supporting an overweight bias, with resistance being tested. The analysis provides specific institutional trading strategies, including position trading, momentum breakout, …

Maxim Group Maintains Aprea Therapeutics(APRE.US) With Buy Rating, Maintains Target Price $5

Maxim Group has reiterated its Buy rating for Aprea Therapeutics (APRE.US) and maintained its price target of $5. This indicates a continued positive outlook from the firm regarding the company's stock performance.

What Does Lantheus Holdings (LNTH) FDA Approval Mean For Its Alzheimer’s Push?

Lantheus Holdings received FDA approval for TAUKLARIFY, a tau PET imaging agent for Alzheimer's disease diagnostics, expanding its molecular imaging portfolio beyond prostate cancer. This approval strengthens Lantheus's position in the Alzheimer's imaging market and supports its strategy of diversifying revenue and meeting the …

Inspire Medical Systems (INSP) Updates Guidance As Valuation Questions Persist

Sotera Health president Rutz sells $2.83m in common stock

Michael P. Rutz, President of Sterigenics (a Sotera Health Co subsidiary), sold 150,000 shares of company stock for approximately $2.83 million on August 7, 2026. This sale occurred while the stock was trading near its 52-week high. The company recently reported strong Q2 2026 …

AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

Edelson Lechtzin LLP, a national class action law firm, is investigating a data breach at AdaptHealth Corp. that exposed patient data. The breach, disclosed on July 2, 2026, involved a social engineering attack that compromised a third-party contractor's credentials, leading to unauthorized access to …

DENTSPLY Sirona Inc (XRAY) News, Articles, Events & Latest Updates

DENTSPLY Sirona Inc. (XRAY) reported a Q2 2026 profit, turning around from a loss in the previous year, driven by improved margins and the absence of prior impairment charges. Despite a 4.1% sales decline due to dental weakness, the company's Wellspect division showed growth, …

Understanding Momentum Shifts in (PACS)

This article analyzes momentum shifts for Pacs Group Inc. (NASDAQ: PACS), highlighting weak near-term sentiment but long-term strength. It details institutional trading strategies, including long, breakout, and short positions, along with multi-timeframe signal analysis to guide investors on support and resistance levels.

Humana (HUM) Beats On Earnings And Quality, Is The Stock Above Fair Value?

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Humana (HUM) is back on investors' radar after a strong earnings beat, fresh quality gains in its insurance operations, new caregiver retention initiatives in …

Analysts' Revenue Estimates For Xencor, Inc. (NASDAQ:XNCR) Are Surging Higher

Xencor, Inc.'s revenue estimates have been significantly upgraded by analysts, signaling increased optimism for the company's future performance. This positive revision comes despite the company not having current revenues, as analysts anticipate strong growth. The upgraded forecasts suggest a bright outlook for Xencor, Inc. …

Vivos Therapeutics, Inc. (VVOS) Reports Q2 Loss, Lags Revenue Estimates

Vivos Therapeutics, Inc. (VVOS) reported a Q2 loss of $0.31 per share, which was better than the Zacks Consensus Estimate of a $0.42 loss. However, the company missed revenue estimates, posting $5.15 million against an expected $5.43 million. Despite beating EPS estimates two out …

Agenus Puts Its BOT+BAL Cancer Combo To The Test

Agenus is a clinical-stage immuno-oncology company focusing on its lead program, the BOT+BAL combination, for various solid tumors. The company is funding Phase 3 trials through an oversubscribed private placement in July 2026, aiming for commercialization and potential approvals. Despite strong recent stock performance …

How TG Therapeutics’ Q2 2026 Revenue Surge And Higher Guidance At TG Therapeutics (TGTX) Has Changed Its Investment Story

US Physical Therapy Appoints New Executive Vice President CFO

Organogenesis (ORGO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Organogenesis Holdings President, Chief Executive Officer, and Chair of the Board - Gary S. Gillheeney, Sr. Chief Financial Officer - David Francisco Full Conference Call Transcript Operator: Welcome, …

Humana Stock Gains 1.1% as 600,000-Member Medicare Reset Tests Its 2028 Margin Plan

Humana (NYSE:HUM) shares rose 1.1% last week as the company navigates a significant Medicare Advantage reset, planning to exit approximately 600,000 members while aiming to retain 40% in other offerings. This strategy is designed to achieve a sustainable pre-tax margin of at least 3% …

RA Capital discloses 9.99% Adicet Bio (ACET) stake with warrant blocker

RA Capital Management, L.P., along with associated entities and individuals, has reported a 9.99% beneficial ownership stake in Adicet Bio, Inc. (ACET) as of June 30, 2026. This ownership includes common stock and pre-funded warrants, which contain a "Beneficial Ownership Blocker" preventing exercises that …

ORMP Price Today: Oramed Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC

This article provides a detailed overview of Oramed Pharmaceuticals Inc. (ORMP) stock, including its current price, market data, and recent performance. It highlights that ORMP is trading at $4.49, reflecting a +2.40% movement, and has shown strong returns over the past month (+9.44%) and …

Zevra Therapeutics (ZVRA) insider files to resell RSU shares via broker

An insider at Zevra Therapeutics (ZVRA) has filed a Form 144 notice to resell up to 42,666 common shares. These shares are linked to restricted stock units granted in June 2025 and are planned for potential sale on NASDAQ. The filing also references previous …

IBRX Stock Extends 5-Day Losing Streak — Retail Traders Pin Hopes On ‘Incredibly Strong’ Anktiva Sales And Earnings Beat

Sarepta Stock Dips After Hours: DMD Drug Blow And CEO Exit Eclipse Q4 Revenue Beat

ALGS Stock Rallies 16% After-Hours On $25M Cash Boost From China Hepatitis B Drug Deal

Is Teva Pharmaceutical Industries (TEVA) A Bargain On Its TEV 408 Phase 2b Move?

Teva Pharmaceutical Industries (TEVA) has advanced its TEV-'408 antibody into a phase 2b trial for nonsegmental vitiligo, following promising phase 1b results. The stock has seen significant returns, but while one narrative suggests it's 10.1% undervalued based on future cash flows, another view highlights …

Kestra Medical Technologies CEO Brian Webster sells $692,214 in stock

Kestra Medical Technologies CEO Brian Webster recently sold $692,214 worth of company stock across three transactions between July 30 and August 3, 2026. These sales were nondiscretionary, executed to cover tax withholding obligations related to restricted stock unit vesting. The company has seen significant …

Immunic (IMUX): Commodore Capital discloses 9.9% stake capped by warrant limits

Commodore Capital LP and its affiliates have filed a Schedule 13G/A, disclosing a 9.9% beneficial ownership stake in Immunic, Inc. (IMUX) as of June 30, 2026. This stake, totaling 1,511,821 shares, includes shares issuable from a Pre-Funded Warrant and Tranche 1 Warrants, with both …

SS Innovations (SSII) CEO reports 10,000-share stock gift, holds 108.6M shares

SS Innovations International, Inc. CEO and Chairman, Sudhir Srivastava, reported a bona fide gift transfer of 10,000 shares of common stock on August 14, 2026. These shares were held indirectly through Sushruta Pvt. Ltd., an entity in which Srivastava holds a controlling interest. Following …

Medtronic (MDT) Wins Health Canada Nod For Affera Heart Rhythm System

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Medtronic (NYSE:MDT) has received Health Canada approval for its Affera Integrated Mapping System and Sphere-9 Catheter for the treatment of atrial fibrillation and …

NVAX Stock Is Rising Even After A Revenue Collapse – Here’s The Catch

Kestra Medical Technologies officer Traci Umberger sells $512,791 By Investing.com

Price to earnings forward of Envoy Medical, Inc. – NASDAQ:COCH

Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Eton Pharmaceuticals (NASDAQ: ETON) saw its shares rise significantly in pre-market trading after reporting stronger-than-expected second-quarter financial results and providing an optimistic revenue guidance for FY26. The company exceeded analyst consensus estimates for both earnings per share and sales. The article also lists other …

TRAX Price Today: First Tracks Biotherapeutics, Inc. Stock Price, Quote & Chart | MEXC

This article provides current stock price information for First Tracks Biotherapeutics, Inc. (TRAX) on MEXC, detailing its live price, market data, and recent performance. It also includes instructions on how to buy TRAX on MEXC and offers a company overview, including its focus on …

Iovance Biotherapeutics, Inc. stock Analysis: 130% Rally & Overbought Signals 2026

Iovance Biotherapeutics, Inc. stock has rallied over 130% in 2026, closing at $6.98, but is showing strong overbought signals across multiple timeframes with daily RSI at 73.02. While the daily trend remains bullish due to strong EMA alignment and positive MACD, the elevated RSI …